Advertisement

FDA Approves First New Non-Opioid Pain Pill in Decades

0
By India Edwards HealthDay Reporter FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain...

Age at First Birth May Influence Later Rheumatoid Arthritis Risk

0

Higher risk seen for women with an age at first birth younger than 26 or older than 35 years

Rheumatoid Arthritis Causally Linked to Prostate Cancer

0

No significant associations seen for SLE or AS with prostate cancer or in reverse MR analyses

Childhood Maltreatment May Up Risk for Immune-Mediated Inflammatory Disorders

0

Significantly higher risk seen for rheumatoid arthritis and psoriasis

GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss

0

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders

Risk for Atherosclerotic CVD Up in Association With Cutaneous Lupus Erythematosus

0

Increased odds of atherosclerotic cardiovascular disease seen in association with CLE and SLE, but not psoriasis

Gout Flares Often Underreported in U.S. Adults With Gout

0

Patients who are younger, less educated, with a lower Charlson Comorbidity Index score less likely to report flares

Immunocompromised Have Heterogeneous Antibody Response to RSV Vaccines

0

Median four-week preF IgG fold rise was 4.21; 61 percent of participants achieved seroconversion

More Than Half of People With Rheumatoid Arthritis Have Anemia

0

Anemia significantly associated with higher disease severity, elevated inflammatory markers

Modest Decline Seen in Portal Messaging With Billing Implementation

0

8.8 percent decrease seen in volume of patient-initiated medical advice message threads in six months after implementation